Literature DB >> 21394809

Up-regulation of VEGF by MC3T3-E1 cells treated with curculigoside.

Chengjian Ma1, Junyu Zhang, Jiehai Fu, Linfang Cheng, Guangshu Zhao, Yaping Gu.   

Abstract

Empirical evidence has shown that curculigoside, the main active compound of the traditionally used Chinese herb, Curculigo orchioides (Amaryllidaceae, rhizome), affects bone formation and fracture healing. However, the mechanistic details of these processes remain unclear. Therefore, the effects of curculigoside on immortalized, pre-osteoblastic mouse MC3T3-E1 cells was investigated. Following treatment with curculigoside, MC3T3-E1 cells exhibited an increased rate of proliferation. Higher levels of vascular endothelial growth factor (VEGF), Fms-like tyrosine kinase-1 (Flt-1) and bone morphogenetic protein-2 (BMP-2) were also detected in cell supernatants and cell lysates by ELISA and western blot analysis, respectively. Furthermore, the stimulatory effect of curculigoside was observed at relatively low doses (i.e. 10-100 μg/mL). In combination, these responses to treatment with curculigoside elucidate mechanistic details underlying the therapeutic effects of Curculigo orchioides on bone, and identifies these molecules as potential targets for the treatment of common metabolic bone diseases.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394809     DOI: 10.1002/ptr.3449

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  5 in total

1.  Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.

Authors:  Vishnu Priya Murali; Girija Kuttan
Journal:  Integr Cancer Ther       Date:  2015-09-29       Impact factor: 3.279

2.  Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures.

Authors:  Mao-Wang Ho; Te-Mao Li; Ju-Pi Li; Jian-Shiun Chiou; Mu-Lin Chiu; Chao-Jung Chen; Chi-Fung Cheng; Fuu-Jen Tsai; Yang-Chang Wu; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Yu-Ning Lin; Chen-Hsing Chou; Wen-Miin Liang; Ying-Ju Lin
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

3.  Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice.

Authors:  Na Wang; Ziyi Li; Shilun Li; Yukun Li; Liu Gao; Xiaoxue Bao; Ke Wang; Chang Liu; Peng Xue; Sijing Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-03

4.  Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption.

Authors:  Liming Xue; Lei Jiao; Yin Wang; Yan Nie; Ting Han; Yiping Jiang; Khalid Rahman; Qiaoyan Zhang; Luping Qin
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-01       Impact factor: 2.629

5.  Curculigoside Protects against Excess-Iron-Induced Bone Loss by Attenuating Akt-FoxO1-Dependent Oxidative Damage to Mice and Osteoblastic MC3T3-E1 Cells.

Authors:  Quanlong Zhang; Lu Zhao; Yi Shen; Yuqiong He; Gang Cheng; Ming Yin; Qiaoyan Zhang; Luping Qin
Journal:  Oxid Med Cell Longev       Date:  2019-12-17       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.